Zhitong Finance App News, Baiyunshan (600332.SH) issued an announcement. Recently, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (“Tianxin Pharmaceutical”), a holding subsidiary of the company, received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration. Amikacin sulfate injection (2ml: 0.2g) (200,000 units) has passed the consistent evaluation of the quality and efficacy of generic drugs.

Amikacin sulfate injection is suitable for severe infections caused by Pseudomonas aeruginosa and other pseudomonas, Escherichia coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter, and other sensitive gram-negative bacilli and staphylococci (methicillin-sensitive strains), such as bacteremia or sepsis, bacterial endocarditis, lower respiratory infections, bone and joint infections, biliary tract infections, abdominal infections, complicated urinary tract infections, skin and soft tissue infections, etc. Since this product is stable to most aminoglycoside passivation enzymes, it is particularly suitable for treating severe infections caused by gram-negative bacilli against kanamycin, gentamicin, or tobramycin resistant strains.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.